16 September 2021

T2D and the heart

Cardio Clinical Diabetes

Dr David Lim and Associate Professor Neale Cohen discuss why GPs need to be aware of potential heart complications in patients with T2DM.


  • In this era of SGLT2 inhibitors and GLP1 agonists, we need to initiate these therapies early because of their cardioprotective and renoprotective (for SGLT2I) benefits
  • The incidence of heart failure, silent ischaemia and arrhythmias are higher in patients with T2DM and GPs need a high index of suspicion to identify, diagnose and treat these

Host: Dr David Lim, GP and medical educator

Guest: Associate Professor Neale Cohen, endocrinologist; Director of clinical diabetes, the Baker Heart and Diabetes Institute, Melbourne

Total time: 27 mins

COVID-19 live update